United States · FDA National Drug Code directory
XENPOZYME
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58468-0050_ce8d4153-ce95-43c4-9672-e1e951ebcdaa
- Product NDC
- 58468-0050
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- olipudase alfa-rpcp
- Labeler
- Genzyme Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 20220829
- Source listing expiry
- 20261231
Source-listed ingredients
- OLIPUDASE ALFA — 20 mg/5.1mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (58468-0050-1) / 5.1 mL in 1 VIAL · 58468-0050-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →